Dividends Calendar Earnings Calendar
ALXN

ALXN | Alexion Pharmaceuticals Inc

155.07 -4.13 (-2.74%) 
Alexion Pharmaceuticals Inc
Category: Pharmaceutical company
  • Industry: Biotechnology

Quick infos

  • Headquarters:   New Haven, Connecticut, United States

Trade prices

  • Volume:
  • Market Cap: 34.4B
  • Prev closed: 106.97
  • Open: 107.13
  • High: 108.91
  • Low: 106.85
  • 52 week low: 94.59
  • 52 week high: 141.86
  • Dividends:No Dividends

Next ER: February 4, 2021  Before Market Opens



Top Stories (ALXN)

    About the Company

    Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria. The company is also involved in immune system research related to autoimmune diseases.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    April 29, 2021
    February 4, 2021- / 2.58- / 1.52B
    October 29, 20203.24 / 2.61.59B / 1.42BBeat!
    July 30, 20203.11 / 2.581.44B / 1.27BBeat!
    May 6, 20203.22 / 2.711.44B / 1.36BBeat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Mar 19, 2021 150.94 150.86
    151.78
    150.35
    2.62M -0.22%
    Mar 18, 2021 151.27 152.53
    153.08
    151.22
    2.26M -1.28%
    Mar 17, 2021 153.23 151.70
    153.69
    151.41
    2.47M -0.09%
    Mar 16, 2021 153.37 154.76
    155.64
    153.09
    4.71M 0.78%
    Mar 15, 2021 152.18 151.56
    152.18
    150.57
    2.37M 0.39%
    Mar 12, 2021 151.59 150.20
    151.76
    149.94
    1.67M 0.09%
    Mar 11, 2021 151.45 152.41
    152.72
    151.37
    3.21M -1.32%
    Mar 10, 2021 153.48 154.64
    154.82
    153.35
    2.95M 0.57%
    Mar 9, 2021 152.61 152.56
    153.73
    152.32
    3.94M 1.70%
    Mar 8, 2021 150.06 149.29
    151.08
    149.20
    3.20M -0.03%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Employees:2,525 (2017)

    News

    News for (ALXN)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  Ludwig N. Hantson (Mar 2017–)

    Talk about Alexion Pharmaceuticals Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Feb 4, 2021 (Same day)

    syna gpro atvi rl newr msi post db xyl abc flt sbh 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 24
    HOLD 76
    SELL 0

    Their Official Profiles 

    WikipediaLinkedInYoutube

    Peers / Similar stocks 

    xlv 

    Other stocks 

    mmm rht fb gnc dltr kr se aobc vsto tal levi info 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Swing Trading For Dummies
    Buy on Amazon

    Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.

    Take advantage of price swings in strongly trending securities and pump up your portfolio!